Form 8-K - Current report:
SEC Accession No. 0001193125-20-227098
Filing Date
2020-08-21
Accepted
2020-08-21 17:00:32
Documents
13
Period of Report
2020-08-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d67771d8k.htm   iXBRL 8-K 49515
2 EX-3.1 d67771dex31.htm EX-3.1 5181
  Complete submission text file 0001193125-20-227098.txt   189486

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20200820.xsd EX-101.SCH 3088
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20200820_lab.xml EX-101.LAB 19659
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20200820_pre.xml EX-101.PRE 12327
6 EXTRACTED XBRL INSTANCE DOCUMENT d67771d8k_htm.xml XML 3691
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 201124063
SIC: 2834 Pharmaceutical Preparations